COGT
Cogent Biosciences, Inc.
Company overview
- Market capitalization
- $5.53B
- Employees
- 258
- Latest publication
- 2026-09-29
About Cogent Biosciences, Inc.
Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -96,405,000USD | -97,352,000USD | -102,492,000USD | -80,930,000USD | -73,529,000USD | -71,986,000USD | -67,927,000USD | -70,634,000USD |
| Operating Income | -102,638,000USD | -103,607,000USD | -99,493,000USD | -83,355,000USD | -75,582,000USD | -74,933,000USD | -73,734,000USD | -75,414,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 4,292,000USD | 0USD |
| Cost Of Revenue | — | 1,155,000USD | 1,177,000USD | — | 1,157,000USD | 1,138,000USD | — | 1,097,000USD |
| Gross Profit | — | -1,155,000USD | -1,177,000USD | — | -1,157,000USD | -1,138,000USD | 2,146,000USD | -1,097,000USD |
| Research Development | — | 75,365,000USD | 74,382,000USD | 68,989,000USD | 61,046,000USD | 63,029,000USD | 62,045,000USD | 63,614,000USD |
| Selling General Administrative | — | 28,242,000USD | 23,934,000USD | 14,366,000USD | 13,379,000USD | 11,904,000USD | 11,689,000USD | 11,800,000USD |
| Unclassified Operating Expenses | — | -1,155,000USD | — | — | — | — | — | — |
| Total Operating Expenses | — | 102,452,000USD | 98,316,000USD | 83,355,000USD | 74,425,000USD | 74,933,000USD | 73,734,000USD | 75,414,000USD |
| Interest Income | — | 7,608,000USD | 5,477,000USD | 3,887,000USD | 2,373,000USD | 2,952,000USD | 3,859,000USD | 4,779,000USD |
| Interest Expense | — | 1,213,000USD | 1,289,000USD | 1,459,000USD | 314,000USD | 0USD | — | 0USD |
| Net Interest Income | — | 6,395,000USD | 4,188,000USD | 2,428,000USD | 2,059,000USD | 2,952,000USD | 3,859,000USD | 4,779,000USD |
| Income Before Tax | — | -97,352,000USD | -102,492,000USD | -80,930,000USD | -73,529,000USD | -71,986,000USD | -67,927,000USD | -70,634,000USD |
| Net Income From Continuing Ops | — | -97,352,000USD | -102,492,000USD | -80,930,000USD | -73,529,000USD | -71,986,000USD | -67,927,000USD | -70,634,000USD |
| Ebit | — | -96,139,000USD | -105,744,000USD | -79,471,000USD | -73,215,000USD | -71,986,000USD | -67,927,000USD | -70,634,000USD |
| Ebitda | — | -94,984,000USD | -104,603,000USD | -78,830,000USD | -72,058,000USD | -70,848,000USD | -66,819,000USD | -69,537,000USD |
| Depreciation And Amortization | — | 1,155,000USD | 1,141,000USD | 641,000USD | 1,157,000USD | 1,138,000USD | 1,108,000USD | 1,097,000USD |
| Reconciled Depreciation | — | 1,155,000USD | 1,141,000USD | 1,147,000USD | 1,157,000USD | 1,138,000USD | 1,108,000USD | 1,097,000USD |
| Total Other Income Expense Net | — | 6,255,000USD | -2,999,000USD | 2,425,000USD | 2,053,000USD | 2,947,000USD | 5,807,000USD | 4,780,000USD |
| Source | 0001193125-26-342393Verified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 22,499,000USD | 8,360,000USD | 6,355,000USD |
| Cost Of Revenue | 4,619,000USD | 4,401,000USD | 3,588,000USD | 5,878,000USD | 147,000USD | 43,709USD | — | — |
| Gross Profit | -4,619,000USD | -4,401,000USD | -3,588,000USD | -5,878,000USD | -147,000USD | 22,499,000USD | 8,360,000USD | 6,355,000USD |
| Research Development | 269,780,000USD | 232,658,000USD | 173,755,000USD | 121,627,000USD | 55,913,000USD | 43,709,000USD | 29,832,000USD | 21,992,000USD |
| Selling General Administrative | 63,583,000USD | 43,281,000USD | 34,375,000USD | 26,212,000USD | 19,638,000USD | 10,968,000USD | 4,680,000USD | 3,433,000USD |
| Unclassified Operating Expenses | -4,619,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 328,744,000USD | 275,939,000USD | 208,130,000USD | 147,839,000USD | 75,551,000USD | 54,677,000USD | 34,512,000USD | 25,425,000USD |
| Operating Income | -333,363,000USD | -275,939,000USD | -208,130,000USD | -147,839,000USD | -75,551,000USD | -32,178,000USD | -26,152,000USD | -19,070,000USD |
| Interest Income | 14,689,000USD | 18,088,000USD | 11,317,000USD | 3,989,000USD | 467,000USD | 267,000USD | 386,000USD | 265,000USD |
| Interest Expense | 3,062,000USD | 0USD | 0USD | 3,989,000USD | 3,131,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | 11,627,000USD | 18,088,000USD | 11,317,000USD | 3,989,000USD | 467,000USD | 267,000USD | 386,000USD | 265,000USD |
| Income Before Tax | -328,937,000USD | -255,859,000USD | -192,410,000USD | -140,241,000USD | -72,273,000USD | -31,833,000USD | -25,492,000USD | -18,124,000USD |
| Net Income | -328,937,000USD | -255,859,000USD | -192,410,000USD | -132,643,000USD | -72,273,000USD | -30,273,000USD | -25,492,000USD | -18,124,000USD |
| Net Income From Continuing Ops | -328,937,000USD | -255,859,000USD | -177,663,000USD | -140,241,000USD | -72,273,000USD | -31,833,000USD | -25,492,000USD | -18,124,000USD |
| Ebit | -325,875,000USD | -255,859,000USD | -192,410,000USD | -147,839,000USD | -72,273,000USD | -32,178,000USD | -26,152,000USD | -19,070,000USD |
| Ebitda | -321,256,000USD | -251,508,000USD | -188,822,000USD | -141,961,000USD | -70,282,000USD | -30,885,000USD | -24,981,000USD | -18,240,000USD |
| Depreciation And Amortization | 4,619,000USD | 4,351,000USD | 3,588,000USD | 5,878,000USD | 1,991,000USD | 1,293,000USD | 1,171,000USD | 830,000USD |
| Reconciled Depreciation | 4,583,000USD | 4,351,000USD | 3,731,000USD | 5,878,000USD | 147,000USD | 1,293,000USD | 1,171,000USD | — |
| Total Other Income Expense Net | 4,426,000USD | 20,080,000USD | 15,720,000USD | 7,598,000USD | 3,278,000USD | 345,000USD | 660,000USD | 946,000USD |
| Income Tax Expense | — | — | — | -7,598,000USD | -467,000USD | -1,560,000USD | -386,000USD | -265,000USD |
| Non Operating Income Net Other | — | — | — | 7,598,000USD | 3,278,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -140,241,000USD | -72,273,000USD | -31,833,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 834,546,000USD | 903,006,000USD | 937,607,000USD | 425,933,000USD | 274,817,000USD | 283,798,000USD | 327,898,000USD | 384,016,000USD |
| Cash And Equivalents | 181,172,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 804,820,000USD | 877,803,000USD | 910,355,000USD | 397,244,000USD | 245,008,000USD | 252,884,000USD | 296,472,000USD | 341,528,000USD |
| Other Current Assets | 12,520,000USD | 11,425,000USD | 9,590,000USD | 6,354,000USD | 7,160,000USD | 7,223,000USD | 9,395,000USD | 6,009,000USD |
| Other Non Current Assets | 1,939,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 302,158,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 59,296,000USD | 57,981,000USD | 63,953,000USD | 62,246,000USD | 58,422,000USD | 49,318,000USD | 55,710,000USD | 53,048,000USD |
| Other Non Current Liabilities | 90,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 532,388,000USD | 607,693,000USD | 636,371,000USD | 302,464,000USD | 155,036,000USD | 218,995,000USD | 256,286,000USD | 314,659,000USD |
| Total Equity Including Noncontrolling Interest | 532,388,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 27,371,000USD | 22,847,000USD | 23,535,000USD | 23,865,000USD | 24,947,000USD | 26,052,000USD | 26,564,000USD | 27,597,000USD |
| Accounts Payable | 7,488,000USD | 13,744,000USD | 9,504,000USD | 16,029,000USD | 16,625,000USD | 14,154,000USD | 12,013,000USD | 15,061,000USD |
| Short Term Debt | 1,489,000USD | 1,383,000USD | 1,547,000USD | 1,706,000USD | 1,658,000USD | 1,611,000USD | 1,565,000USD | 1,520,000USD |
| Common Stock | 171,000USD | 171,000USD | 161,000USD | 141,000USD | 114,000USD | 114,000USD | 110,000USD | 110,000USD |
| Retained Earnings | -1,382,177,000USD | -1,285,772,000USD | -1,188,420,000USD | -1,085,928,000USD | -1,004,998,000USD | -931,469,000USD | -859,483,000USD | -791,556,000USD |
| Accumulated Other Comprehensive Income | -770,000USD | -415,000USD | 355,000USD | 208,000USD | 13,000USD | 164,000USD | 447,000USD | 896,000USD |
| Total Liab | — | 295,313,000USD | 301,236,000USD | 123,469,000USD | 119,781,000USD | 64,803,000USD | 71,612,000USD | 69,357,000USD |
| Other Current Liab | — | 42,854,000USD | 52,902,000USD | 44,511,000USD | 40,139,000USD | 33,553,000USD | 42,132,000USD | 36,467,000USD |
| Capital Stock | — | 64,924,000USD | 89,554,000USD | 108,056,000USD | 108,029,000USD | 108,279,000USD | 110,710,000USD | 110,710,000USD |
| Cash | — | 241,208,000USD | 312,012,000USD | 125,297,000USD | 127,598,000USD | 126,003,000USD | 98,165,000USD | 97,045,000USD |
| Cash And Short Term Investments | — | 866,378,000USD | 900,765,000USD | 390,890,000USD | 237,848,000USD | 245,661,000USD | 287,077,000USD | 335,519,000USD |
| Net Debt | — | -2,555,000USD | -58,860,000USD | -64,738,000USD | -66,940,000USD | -108,912,000USD | -80,698,000USD | -79,216,000USD |
| Short Long Term Debt Total | — | 238,653,000USD | 253,152,000USD | 60,559,000USD | 60,658,000USD | 17,091,000USD | 17,467,000USD | 17,829,000USD |
| Long Term Debt | — | 223,173,000USD | 222,895,000USD | 44,250,000USD | 43,949,000USD | — | — | — |
| Short Term Investments | — | 625,170,000USD | 588,753,000USD | 265,593,000USD | 110,250,000USD | 119,658,000USD | 188,912,000USD | 238,474,000USD |
| Property Plant Equipment Gross | — | 22,847,000USD | 32,214,000USD | 23,865,000USD | 24,947,000USD | 26,052,000USD | 32,679,000USD | 27,597,000USD |
| Common Stock Shares Outstanding | — | 67,414,000shares | 67,600,000shares | 114,466,080shares | 114,466,080shares | 113,307,940shares | 110,461,729shares | 110,165,580shares |
| Non Current Assets Total | — | 25,202,999USD | 27,252,000USD | 28,689,000USD | 29,809,000USD | 30,914,000USD | 31,426,000USD | 42,488,000USD |
| Non Current Liabilities Total | — | 237,332,000USD | 237,283,000USD | 61,223,000USD | 61,359,000USD | 15,485,000USD | 15,902,000USD | 16,309,000USD |
| Non Current Liabilities Other | — | 62,000USD | 33,000USD | 2,370,000USD | 2,359,000USD | 5,000USD | — | — |
| Non Currrent Assets Other | — | 1,939,999USD | 3,717,000USD | 4,824,000USD | 4,862,000USD | 4,862,000USD | 4,862,000USD | 4,862,000USD |
| Net Working Capital | — | 819,822,000USD | 846,402,000USD | 334,998,000USD | 186,586,000USD | 203,566,000USD | 240,762,000USD | 288,480,000USD |
| Unclassified Non Current Liabilities | — | 14,097,000USD | 14,355,000USD | 14,603,000USD | 15,051,000USD | 15,480,000USD | 15,902,000USD | 16,309,000USD |
| Unclassified Equity | — | 1,828,785,000USD | 1,734,721,000USD | 1,279,987,000USD | 1,051,878,000USD | 1,041,907,000USD | 1,004,502,000USD | 994,499,000USD |
| Long Term Investments | — | — | — | — | — | — | 0USD | 10,029,000USD |
| Source | 0001193125-26-342393DeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 937,607,000USD | 327,898,000USD | 313,437,000USD | 300,810,000USD | 232,092,000USD | 250,916,000USD | 49,423,000USD | 85,927,000USD |
| Other Current Assets | 9,590,000USD | 9,395,000USD | 5,061,000USD | 5,690,000USD | 2,949,000USD | 2,722,000USD | 1,167,000USD | 1,480,000USD |
| Total Liab | 301,236,000USD | 71,612,000USD | 55,635,000USD | 45,075,000USD | 17,908,000USD | 16,249,000USD | 17,661,000USD | 25,693,000USD |
| Total Stockholder Equity | 636,371,000USD | 256,286,000USD | 257,802,000USD | 255,735,000USD | 214,184,000USD | 234,667,000USD | 31,762,000USD | 60,234,000USD |
| Other Current Liab | 52,902,000USD | 42,132,000USD | 26,127,000USD | 17,884,000USD | 8,210,000USD | 10,310,000USD | 7,131,000USD | 5,477,000USD |
| Common Stock | 161,000USD | 110,000USD | 86,000USD | 70,000USD | 44,000USD | 32,000USD | 8,000USD | 30,000USD |
| Capital Stock | 89,554,000USD | 110,710,000USD | 60,121,000USD | 65,900,000USD | 85,444,000USD | 110,913,000USD | 30,000USD | 30,000USD |
| Retained Earnings | -1,188,420,000USD | -859,483,000USD | -603,624,000USD | -411,214,000USD | -270,973,000USD | -198,700,000USD | -123,892,000USD | -92,059,000USD |
| Cash | 312,012,000USD | 98,165,000USD | 53,229,000USD | 139,886,000USD | 219,684,000USD | 242,190,000USD | 37,424,000USD | 55,671,000USD |
| Cash And Short Term Investments | 900,765,000USD | 287,077,000USD | 265,710,000USD | 259,276,000USD | 219,684,000USD | 242,190,000USD | 37,424,000USD | 78,594,000USD |
| Total Current Assets | 910,355,000USD | 296,472,000USD | 270,771,000USD | 264,966,000USD | 222,633,000USD | 244,912,000USD | 40,591,000USD | 81,002,000USD |
| Total Current Liabilities | 63,953,000USD | 55,710,000USD | 38,168,000USD | 26,849,000USD | 17,077,000USD | 13,094,000USD | 13,248,000USD | 24,945,000USD |
| Net Debt | -58,860,000USD | -80,698,000USD | -34,376,000USD | -120,237,000USD | -216,529,000USD | -236,983,000USD | -31,392,000USD | -55,671,000USD |
| Short Term Debt | 1,547,000USD | 1,565,000USD | 1,386,000USD | 1,423,000USD | 2,324,000USD | 2,052,000USD | 1,619,000USD | 3,798,000USD |
| Short Long Term Debt Total | 253,152,000USD | 17,467,000USD | 18,853,000USD | 19,649,000USD | 3,155,000USD | 5,207,000USD | 6,032,000USD | — |
| Long Term Debt | 222,895,000USD | — | — | — | — | — | — | — |
| Short Term Investments | 588,753,000USD | 188,912,000USD | 212,481,000USD | 119,390,000USD | 0USD | — | 0USD | 22,923,000USD |
| Accounts Payable | 9,504,000USD | 12,013,000USD | 10,655,000USD | 5,842,000USD | 3,483,000USD | 732,000USD | 3,183,000USD | 1,519,000USD |
| Property Plant Equipment Net | 23,535,000USD | 26,564,000USD | 30,342,000USD | 31,099,000USD | 4,477,000USD | 4,749,000USD | 7,150,000USD | 3,251,000USD |
| Property Plant Equipment Gross | 32,214,000USD | 32,679,000USD | 34,007,000USD | 32,500,000USD | 5,036,000USD | 4,749,000USD | 7,150,000USD | 3,251,000USD |
| Accumulated Other Comprehensive Income | 355,000USD | 447,000USD | 246,000USD | -104,000USD | 0USD | — | 0USD | -12,000USD |
| Common Stock Shares Outstanding | 67,600,000shares | 103,856,611shares | 79,657,942shares | 58,739,713shares | 38,730,813shares | 11,081,257shares | 7,620,082shares | 6,223,917shares |
| Non Current Assets Total | 27,252,000USD | 31,426,000USD | 42,666,000USD | 35,844,000USD | 9,459,000USD | 6,004,000USD | 8,832,000USD | 4,925,000USD |
| Non Current Liabilities Total | 237,283,000USD | 15,902,000USD | 17,467,000USD | 18,226,000USD | 831,000USD | 3,155,000USD | 4,413,000USD | 748,000USD |
| Non Current Liabilities Other | 33,000USD | — | — | 18,226,000USD | 831,000USD | 3,155,000USD | — | — |
| Non Currrent Assets Other | 3,717,000USD | 4,862,000USD | 4,864,000USD | 4,745,000USD | 3,727,000USD | 1,255,000USD | 1,682,000USD | 419,000USD |
| Net Working Capital | 846,402,000USD | 240,762,000USD | 232,603,000USD | 238,117,000USD | 205,556,000USD | 231,818,000USD | 27,343,000USD | 56,057,000USD |
| Unclassified Non Current Liabilities | 14,355,000USD | 15,902,000USD | 17,467,000USD | — | — | — | 4,413,000USD | — |
| Unclassified Equity | 1,734,721,000USD | 1,004,502,000USD | 800,973,000USD | 601,083,000USD | 399,669,000USD | 322,422,000USD | 155,616,000USD | 152,245,000USD |
| Long Term Investments | — | 0USD | 7,460,000USD | 0USD | — | — | — | — |
| Current Deferred Revenue | — | — | 25,686,000USD | 1,700,000USD | 3,060,000USD | 3,795,000USD | 1,315,000USD | 17,949,000USD |
| Unclassified Current Liabilities | — | — | -25,686,000USD | — | — | -3,795,000USD | — | -3,798,000USD |
| Other Assets | — | — | — | 4,745,000USD | 4,982,000USD | 5,870,000USD | 1,682,000USD | — |
| Net Tangible Assets | — | — | — | 189,905,000USD | 128,784,000USD | 123,786,000USD | 31,762,000USD | — |
| Unclassified Non Current Assets | — | — | — | -4,745,000USD | -3,727,000USD | -5,870,000USD | -1,682,000USD | 1,255,000USD |
| Net Receivables | — | — | — | — | — | 0USD | 2,000,000USD | 1,668,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,367,000USD |
| Stock Based Compensation | 34,015,000USD |
| Change To Liabilities | -4,542,000USD |
| Change In Working Capital | -2,135,000USD |
| Operating Cash Flow | -164,154,000USD |
| Capital Expenditures | -819,000USD |
| Net Investments | -21,358,000USD |
| Investing Cash Flow | -22,177,000USD |
| Net Debt Issuance | 0USD |
| Unclassified Financing Cash Flow | 55,491,000USD |
| Financing Cash Flow | 55,491,000USD |
| Change In Cash | -130,840,000USD |
| End Cash Flow | 181,588,000USD |
| Source | 0001193125-26-342393DeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -97,352,000USD | -102,492,000USD | -80,930,000USD | -73,529,000USD | -71,986,000USD | -67,927,000USD | -70,634,000USD | -58,950,000USD |
| Depreciation | 1,155,000USD | 1,141,000USD | 1,147,000USD | 1,157,000USD | 1,138,000USD | 1,108,000USD | 1,097,000USD | 1,080,000USD |
| Stock Based Compensation | 16,908,000USD | 15,751,000USD | 10,604,000USD | 9,716,000USD | 10,008,000USD | 9,977,000USD | 10,358,000USD | 10,012,000USD |
| Other Non Cash Items | -767,000USD | 6,363,000USD | 133,000USD | 279,000USD | -955,000USD | -2,604,000USD | -6,200,000USD | 2,581,000USD |
| Change In Working Capital | -6,827,000USD | 132,000USD | 4,760,000USD | 7,835,000USD | -4,716,000USD | -1,131,000USD | 13,395,000USD | 2,576,000USD |
| Total Cash From Operating Activities | -86,883,000USD | -79,105,000USD | -64,286,000USD | -54,542,000USD | -66,511,000USD | -60,577,000USD | -51,984,000USD | -42,701,000USD |
| Capital Expenditures | -449,000USD | -811,000USD | -65,000USD | -131,000USD | -547,000USD | -75,000USD | -280,000USD | -148,000USD |
| Free Cash Flow | -87,332,000USD | -79,916,000USD | -64,351,000USD | -54,673,000USD | -67,058,000USD | -60,652,000USD | -52,264,000USD | -42,849,000USD |
| Investments | -36,008,000USD | -321,958,000USD | -155,046,000USD | 8,910,000USD | 69,379,000USD | 61,671,000USD | 60,186,000USD | -84,625,000USD |
| Total Cashflows From Investing Activities | -36,457,000USD | -322,769,000USD | -155,046,000USD | 8,910,000USD | 69,379,000USD | 61,671,000USD | 60,186,000USD | -84,625,000USD |
| Total Cash From Financing Activities | 52,536,000USD | 588,669,000USD | 217,367,000USD | 47,227,000USD | 24,970,000USD | 26,000USD | 624,000USD | -256,000USD |
| Sale Purchase Of Stock | 1,062,000USD | — | — | — | — | — | — | — |
| Issuance Of Capital Stock | 45,712,000USD | -80,719,000USD | 215,792,000USD | 0USD | 24,250,000USD | 0USD | 0USD | -365,000USD |
| Change In Cash | -70,804,000USD | 186,715,000USD | -2,301,000USD | 1,595,000USD | 27,838,000USD | 1,120,000USD | 8,826,000USD | -127,582,000USD |
| Begin Period Cash Flow | 312,428,000USD | 125,297,000USD | 127,598,000USD | 126,003,000USD | 98,165,000USD | 97,045,000USD | 88,219,000USD | 215,801,000USD |
| End Period Cash Flow | 241,624,000USD | 312,012,000USD | 125,297,000USD | 127,598,000USD | 126,003,000USD | 98,165,000USD | 97,045,000USD | 88,219,000USD |
| Other Cashflows From Financing Activities | 52,536,000USD | -48,896,000USD | 217,367,000USD | 47,227,000USD | 720,000USD | 213,362,000USD | 624,000USD | 109,000USD |
| Unclassified Financing Cash Flow | -1,062,000USD | 549,819,000USD | -215,792,000USD | — | — | -213,336,000USD | — | — |
| Net Borrowings | — | 168,465,000USD | 0USD | — | — | — | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -328,937,000USD | -255,859,000USD | -192,410,000USD | -72,273,000USD | -74,808,000USD | -34,532,000USD | -25,492,000USD | -18,124,000USD |
| Depreciation | 4,583,000USD | 4,351,000USD | 3,588,000USD | 147,000USD | 720,000USD | 1,321,000USD | 1,171,000USD | 830,000USD |
| Stock Based Compensation | 46,079,000USD | 39,740,000USD | 30,621,000USD | 11,686,000USD | 6,017,000USD | 3,088,000USD | 1,341,000USD | 1,016,000USD |
| Other Non Cash Items | 5,820,000USD | -7,619,000USD | -6,865,000USD | -343,000USD | 37,537,000USD | 23,000USD | 7,000USD | -56,000USD |
| Change In Working Capital | 8,010,999USD | 11,596,000USD | 11,442,000USD | 2,020,000USD | -5,316,000USD | -2,153,000USD | -2,879,000USD | -2,323,000USD |
| Total Cash From Operating Activities | -264,444,000USD | -207,791,000USD | -153,624,000USD | -58,763,000USD | -35,850,000USD | -32,489,000USD | -25,835,000USD | -18,640,000USD |
| Capital Expenditures | -1,554,000USD | -573,000USD | -2,796,000USD | -1,719,000USD | -320,000USD | -549,000USD | -912,000USD | -3,307,000USD |
| Free Cash Flow | -265,998,000USD | -208,364,000USD | -156,420,000USD | -60,482,000USD | -35,850,000USD | -33,038,000USD | -26,747,000USD | -21,947,000USD |
| Investments | -397,972,000USD | 38,276,000USD | -79,902,000USD | -1,719,000USD | 8,420,000USD | -10,531,000USD | 13,513,000USD | -30,429,000USD |
| Total Cashflows From Investing Activities | -399,526,000USD | 38,276,000USD | -97,824,000USD | -1,719,000USD | 8,420,000USD | -10,531,000USD | 13,513,000USD | -30,429,000USD |
| Net Borrowings | 217,756,000USD | 0USD | 0USD | — | — | — | — | — |
| Total Cash From Financing Activities | 878,233,000USD | 214,451,000USD | 163,536,000USD | 37,976,000USD | 232,196,000USD | 70,346,000USD | -729,000USD | -40,000USD |
| Issuance Of Capital Stock | 159,323,000USD | 213,336,000USD | 161,819,000USD | 38,006,000USD | 231,636,000USD | 71,793,000USD | — | — |
| Change In Cash | 214,263,000USD | 44,936,000USD | -87,912,000USD | -22,506,000USD | 204,766,000USD | 27,326,000USD | -13,051,000USD | -49,109,000USD |
| Begin Period Cash Flow | 98,165,000USD | 53,229,000USD | 141,141,000USD | 243,445,000USD | 38,679,000USD | 29,600,000USD | 41,321,000USD | 90,430,000USD |
| End Period Cash Flow | 312,428,000USD | 98,165,000USD | 53,229,000USD | 220,939,000USD | 243,445,000USD | 56,926,000USD | 28,270,000USD | 41,321,000USD |
| Other Cashflows From Financing Activities | -48,896,000USD | 1,115,000USD | 1,717,000USD | -30,000USD | 99,467,000USD | -1,447,000USD | -789,000USD | -40,000USD |
| Unclassified Financing Cash Flow | 550,050,000USD | — | — | 37,951,000USD | 8,262,000USD | — | — | — |
| Other Cashflows From Investing Activities | — | 38,276,000USD | — | — | 8,420,000USD | — | -75,000USD | 50,000USD |
| Unclassified Investing Cash Flow | — | -37,703,000USD | -15,126,000USD | 1,719,000USD | -8,100,000USD | — | — | 3,257,000USD |
| Change To Account Receivables | — | — | — | 0USD | 2,000,000USD | -838,000USD | 98,000USD | -634,000USD |
| Change To Liabilities | — | — | — | 6,182,000USD | -3,766,000USD | — | — | — |
| Sale Purchase Of Stock | — | — | — | 55,000USD | 124,467,000USD | — | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -22,506,000USD | 204,766,000USD | — | — | — |
| Change To Inventory | — | — | — | — | -3,550,000USD | 2,214,000USD | 931,000USD | 784,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.